Phenotypic switching and prostate diseases: a model proposing a causal link between benign prostatic hyperplasia and prostate cancer

2020 ◽  
pp. 569-589
Author(s):  
Prakash Kulkarni ◽  
Anusha Nathan ◽  
Ravi Salgia ◽  
Govindan Rangarajan ◽  
Mohit Kumar Jolly
2015 ◽  
Vol 84 (2) ◽  
pp. 97-103
Author(s):  
Joanna Bartkowiak-Wieczorek ◽  
Radosław Kujawski ◽  
Anna Bogacz ◽  
Marcin Ożarowski

The usage of classical pharmacological treatment of prostate diseases causes the risk of a number of side effects therefore the researchers are looking for new pharmacologically active molecules, including those contained in the plant extracts. The most widely studied is the lipido-sterolic extract from Serenoa repens (saw palmetto), water extract from Camellia sinensis (green tea) and several cruciferous vegetables. The molecular mechanisms underlying of the development and the progression of prostate disorders, especially benign prostatic hyperplasia (BPH) and prostate cancer (PC), remain still poorly understood. The development of pathologically changed prostate cells proliferation involves many factors, including genetic alterations, such as mutations, and epigenetic changes, appear to contribute to the transformation and progression of prostate cancer. In this paper we suggest that the knowledge of epigenetic modifications presented in this paper introduces the new point of view concerning the possibility of action of plant substances used in prevention and symptomatic treatment of BPH and prostate cancer. Thus, identification of the epigenetic modifications involved on the one hand in the development and progression of BPH / PC, on the other influencing the efficacy and safety of potential phytotherapeutics will be helpful in identifying its novel therapeutic strategy.


Author(s):  
Shuiping Yin ◽  
Dandan Xu ◽  
Meng Zhang ◽  
Peiyu Zhang ◽  
Yu Guan ◽  
...  

IntroductionMicrobial structure is closely associated with the initiation and development of various diseases. However, the roles of urine flora in prostate diseases, including prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are still unclear.Material and methodsIn this study, clinical samples were collected from PCa (n=21) and BPH (n=19) patients and healthy people (n=12). The analysis of urine flora DNA sequencing and hematological testing results between every two groups was performed by using bioinformatic methods, including alpha and beta diversity analysis, and functional PICRUSt analysis.ResultsThe results showed that the microbial structure in PCa and BPH differentiated from healthy control. Escherichia coli was increased in PCa and BPH patients, while probiotics, such as, Lactobacillus helveticus and Lactobacillus iners was decreased. Moreover, beta diversity in PCa group was different with control group, while alpha diversity showed no significant changes. Spearman analysis showed that Escherichia coli was negatively correlated with Lactobacillus helveticus and Lactobacillus iners. Microbial imbalance was associated with energy metabolism in PCa and with cell motility, energy metabolism, and intracellular trafficking, secretion, and vesicular transport in BPH. Moreover, microbial imbalance was associated with nervous disorders and infectious diseases in PCa, and with metabolic system, infectious diseases, and signal transduction BPH.ConclusionsTaken together, microbial imbalance may be associated with PCa and BPH. The increase of Escherichia coli was accompanied by the decrease of probiotics, such as Lactobacillus helveticus and Lactobacillus iners. This may be the biomarkers for risk prediction and early treatment for prostate disease.


2022 ◽  
Vol 23 (2) ◽  
pp. 897
Author(s):  
Weronika Ratajczak ◽  
Michał Lubkowski ◽  
Anna Lubkowska

Two out of three diseases of the prostate gland affect aging men worldwide. Benign prostatic hyperplasia (BPH) is a noncancerous enlargement affecting millions of men. Prostate cancer (PCa) in turn is the second leading cause of cancer death. The factors influencing the occurrence of BPH and PCa are different; however, in the course of these two diseases, the overexpression of heat shock proteins is observed. Heat shock proteins (HSPs), chaperone proteins, are known to be one of the main proteins playing a role in maintaining cell homeostasis. HSPs take part in the process of the proper folding of newly formed proteins, and participate in the renaturation of damaged proteins. In addition, they are involved in the transport of specific proteins to the appropriate cell organelles and directing damaged proteins to proteasomes or lysosomes. Their function is to protect the proteins against degradation factors that are produced during cellular stress. HSPs are also involved in modulating the immune response and the process of apoptosis. One well-known factor affecting HSPs is the androgen receptor (AR)—a main player involved in the development of BPH and the progression of prostate cancer. HSPs play a cytoprotective role and determine the survival of cancer cells. These chaperones are often upregulated in malignancies and play an indispensable role in tumor progression. Therefore, HSPs are considered as one of the therapeutic targets in anti-cancer therapies. In this review article, we discuss the role of different HSPs in prostate diseases, and their potential as therapeutic targets.


2004 ◽  
Vol 171 (4S) ◽  
pp. 125-125
Author(s):  
Lizhong Wang ◽  
Kazunari Sato ◽  
Norihiko Tsuchiya ◽  
Chikara Ohyama ◽  
Shigeru Satoh ◽  
...  

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Vipin Sharma ◽  
Rita Rana ◽  
Ruma Baksi ◽  
Swapnil P. Borse ◽  
Manish Nivsarkar

Medicines ◽  
2021 ◽  
Vol 8 (6) ◽  
pp. 30
Author(s):  
Teow J. Phua

Background: The etiology of benign prostatic hyperplasia and prostate cancer are unknown, with ageing being the greatness risk factor. Methods: This new perspective evaluates the available interdisciplinary evidence regarding prostate ageing in terms of the cell biology of regulation and homeostasis, which could explain the timeline of evolutionary cancer biology as degenerative, inflammatory and neoplasm progressions in these multifactorial and heterogeneous prostatic diseases. Results: This prostate ageing degeneration hypothesis encompasses the testosterone-vascular-inflamm-ageing triad, along with the cell biology regulation of amyloidosis and autophagy within an evolutionary tumorigenesis microenvironment. Conclusions: An understanding of these biological processes of prostate ageing can provide potential strategies for early prevention and could contribute to maintaining quality of life for the ageing individual along with substantial medical cost savings.


1996 ◽  
Vol 32 (4) ◽  
pp. 627-630 ◽  
Author(s):  
K. Jung ◽  
M. Lein ◽  
S. Weiss ◽  
D. Schnorr ◽  
W. Henke ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document